Metabolite Profiling and Identification: Enhancing Drug Discovery

  • 1.00 Dollar US$
  • Published date: October 23, 2026
    • Shirley, New York, United States

The process of discovering and developing pharmaceuticals involves a complex series of steps aimed at understanding how compounds behave in biological systems. One of the critical components of this process is metabolite profiling and identification, which provides vital insights into the metabolism of drug candidates.

Importance of Metabolite Identification
Successful drug development relies significantly on understanding how a compound is transformed within the body. Metabolite identification helps determine:

The types of biotransformations that occur.
The metabolic sites where these transformations happen.
How these processes influence bioavailability and pharmacokinetics.
As drug discovery progresses, the need for detailed metabolite data increases. This information plays a foundational role not only for optimizing compounds but also for ensuring compliance with regulatory frameworks required for drug approval.

Creative Bioarray’s Approach
At Creative Bioarray, we leverage advanced technology and expert knowledge in metabolite profiling. Our comprehensive suite of services includes:

Accurate identification and characterization of metabolites derived from both in vitro and in vivo studies.
Synthetic chemistry services for creating metabolites, reference standards, and internal standards to assist with method development.
Customizable study designs tailored to specific research requirements.
Capabilities in Metabolite Characterization
Our metabolite characterization services include:

Testing of small molecule articles.
Structure-based study designs that are customized according to individual project needs.
Utilization of various in vitro test systems, including hepatocytes and microsomes.
We also focus on optimizing reaction conditions to enhance metabolite yield and abundance, ensuring high-quality results for our clients.

Advanced Technical Equipment
Our state-of-the-art analytical capabilities comprise:

High-Performance Liquid Chromatography (HPLC) and Ultra-Performance Liquid Chromatography (UPLC).
Mass spectrometry techniques, including LC-MS and GC-MS.
Nuclear Magnetic Resonance (NMR) spectroscopy.
This equipment allows us to conduct detailed analyses and provide rich data sets that inform subsequent drug development stages.

Conclusion: Your Partner in Drug Development
By utilizing our metabolite identification services at Creative Bioarray, clients can access comprehensive data to guide their drug discovery efforts. Our dedicated team is committed to delivering reliable results that facilitate the successful progression of pharmaceutical products.

https://dda.creative-bioarray.com/metabolite-identification.html

Result 0 votes
Hannah Cole
0 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • LLC

    LLC

    Immunology Shirley (New York) September 30, 2026 1.00 Dollar US$

    Cat.No. CSC-C6592J Description Highly metastatic and drug-resistant mouse tumor. Application consideration Species Mus musculus (Mouse) Source Lung https://www.creative-bioarray.com/llc-item-csc-c6592j-43466.htm

  • HCA-7 Colony 26

    HCA-7 Colony 26

    Immunology Shirley (New York) September 30, 2026 1.00 Dollar US$

    Cat.No. CSC-C9466J Description Subpopulation isolated from the HCA-7 cell line Species Homo sapiens (Human) Source Intestine; Colon https://www.creative-bioarray.com/HCA-7-Colony-26-CSC-C9466J-item-42404.htm

  • B16 F10

    B16 F10

    Immunology Shirley (New York) September 30, 2026 1.00 Dollar US$

    Cat.No. CSC-C9336L Description established from the skin of C57BL/6J mouse with B16 melanoma tumor Species Mus musculus (Mouse) Source Skin https://www.creative-bioarray.com/b16-f10-csc-c9336l-item-39483.htm